Nuvan Augustin Dassanaike
SVP, Digital and Marketing Strategy & Operations
Accord Biopharma
Strategic Thinking Is Key To Operational Excellence
Nuvan Dassanaike is a seasoned leader in the pharmaceutical industry with a proven track record of driving growth in competitive markets. His tenure at Accord BioPharma exemplifies his commitment to innovation, strategic thinking, and operational excellence.
As a key member of the founding team, Nuvan helped lead Accord BioPharma’s triumphant entry into the U.S. market, and piloted the launch of its inaugural oncology product for prostate cancer patients. Despite facing stiff competition from established players, Nuvan’s strategic foresight and meticulous planning drove a successful market entry, firmly establishing Accord BioPharma as a formidable contender in the industry.
Nuvan closely collaborated with Asentech to implement a cutting-edge marketing technology foundation at Accord BioPharma. He activated owned channels from the outset to guide the collection of first-party data and capture all interactions between healthcare providers and the brand. In addition, he initiated a customer data platform that expedited dynamic segmentation and personalized messaging. This empowered the brand to engage with target audiences in a more meaningful and personalized way.
“Nuvan helped lead Accord BioPharma’s triumphant entry into the U.S. market, and piloted the launch of its inaugural oncology product for prostate cancer patients.”
He fostered a collaboration between sales and marketing teams to drive unified messaging strategies between brand and targeted HCPs and added significant value to the optimization of the administrative workflow at large Urology practices. Through the AccordConnects mobile app, he revolutionized the way healthcare practices manage inventory.
Nuvan’s success prompted his European colleagues to activate and integrate an “above-brand” HCP hub and marketing automation platform across multiple European markets. His proficiency in navigating compliance, language, and harmonization requirements, alongside differences in marketing infrastructure and consent regulations across EU markets positioned him as a trusted subject matter expert. He championed their aspirations, advocating on their behalf and securing leadership buy-ins from area and country leadership.
Nuvan’s visionary leadership and unwavering commitment to excellence were instrumental in Accord BioPharma’s remarkable market share growth in their first launch. Under his leadership, the brand achieved nearly 20 percent market share within just two years, a testament to his innovative marketing strategies and exceptional leadership capabilities.